HWA
IDXX icon

HCR Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

HCR Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-366
Closed -$206K – 260
2026
Q1 		$206K Buy
366
+4
+1% +$2.56K 0.02% 235
2025
Q4 		$245K Hold
362
– – 0.02% 217
2025
Q3 		$229K Buy
+362
New +$220K 0.02% 217
2024
Q1 		– Sell
-362
Closed -$201K – 228
2023
Q4 		$201K Buy
+362
New +$170K 0.03% 199
2020
Q3 		– Sell
-720
Closed -$241K – 247
2020
Q2 		$241K Buy
+720
New +$208K 0.06% 134
2019
Q3 		– Sell
-790
Closed -$218K – 153
2019
Q2 		$218K Buy
+790
New +$195K 0.06% 143

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HCR Wealth Advisors's IDXX Position: Q2 2026 in Review

HCR Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 366 shares — an estimated $206K sold.

HCR Wealth Advisors first reported a position in IDXX in Q2 2019 and held it in 6 quarters. The position peaked at $245K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • HCR Wealth Advisors reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • HCR Wealth Advisors sold 366 Idexx Laboratories shares in Q2 2026, an estimated $206K.
  • HCR Wealth Advisors first reported a position in Idexx Laboratories in Q2 2019 and held it in 6 quarters.
  • HCR Wealth Advisors's Idexx Laboratories position peaked at $245K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on HCR Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.